Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes

Shinichi Okada1, Kenichi Shikata, Mitsuhiro Matsuda

  • 1Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.

Diabetes
|September 30, 2003
PubMed

Insights

Intercellular adhesion molecule-1 (ICAM-1) plays a key role in diabetic nephropathy. Blocking ICAM-1 reduces inflammation and kidney damage in diabetic mice, suggesting it

Area of Science:

  • Nephrology
  • Immunology
  • Diabetology

Background:

  • Diabetic nephropathy is a major cause of kidney failure.
  • Inflammatory processes are implicated in diabetic kidney disease, but their role is not fully understood.
  • Intercellular adhesion molecule-1 (ICAM-1) mediates macrophage infiltration in diabetic kidneys.

Purpose of the Study:

  • To investigate the role of ICAM-1 in the pathogenesis of diabetic nephropathy.
  • To assess the impact of ICAM-1 deficiency on kidney pathology in a mouse model of diabetes.

Main Methods:

  • Diabetes was induced in ICAM-1-deficient (ICAM-1(-/-)) and wild-type (ICAM-1(+/+)) mice using streptozotocin.
  • Renal pathology was examined over a 6-month period.
  • Macrophage infiltration, urinary albumin excretion, glomerular hypertrophy, mesangial matrix expansion, and expression of TGF-beta and type IV collagen were assessed.

Main Results:

  • Macrophage infiltration was significantly reduced in diabetic ICAM-1(-/-) mice compared to diabetic ICAM-1(+/+) mice.
  • Diabetic ICAM-1(-/-) mice exhibited lower urinary albumin excretion, glomerular hypertrophy, and mesangial matrix expansion.
  • Expressions of TGF-beta and type IV collagen were suppressed in the glomeruli of diabetic ICAM-1(-/-) mice.

Conclusions:

  • ICAM-1 is critically involved in the pathogenesis of diabetic nephropathy.
  • Targeting ICAM-1 may offer a therapeutic strategy for diabetic kidney disease.